Picture of China NT Pharma Co logo

1011 China NT Pharma Co Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual cashflow statement for China NT Pharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-200-149-54.3-33.4-53.5
Depreciation
Amortisation
Non-Cash Items66.664.782.7-2.740.6
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital135-93-13.280.73.15
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities26.2-13536.250.5-9.07
Capital Expenditures-23.8-0.646-4.49-10.7-0.178
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items6192589.02-11.4-0.011
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities5962584.53-22.1-0.189
Financing Cash Flow Items-66.1-43.3-19.7-19.2-9.98
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-624-125-46.7-2912.7
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-20.41.61-2.45-0.3968.1